Unilever Stock News

Unilever CEO Alan Jope discusses the company's fourth-quarter and full-year earnings, plus potentially transformational acquisitions for the company.

The consumer-goods giant reported higher quarterly sales growth but warned its profit margin would fall sharply this year as it grapples with the impact of surging costs around the world.

The consumer-goods giant reported higher quarterly sales growth but warned its profit margin would fall sharply this year as it grapples with the impact of surging costs around the world.

The company predicts it will not be able to fully pass on the surge in costs for things like ingredients and shipping as it reveals a leap in sales Read More The post Unilever: Consumer goods giant warns shoppers of more price rises as costs continue to rocket. appeared first on DailyGuide Network .

The consumer giant, which makes products ranging from Marmite to Ben & Jerry''s ice cream, said it had listened to investor concerns about the potential deal.

The consumer goods group said it expects underlying sales growth in 2022 to be in a range of 4.5% to 6.5%.

LONDON (Reuters) Unilever warned of a hit to profit margins this year as it struggles to pass on higher costs to consumers, and ruled out big acquisitions following recent investor criticism of its failed pursuit of GlaxoSmithKlines consumer health business. Consumer goods companies like Unilever are grappling with a surge in raw material, energy, Read More

Unilever PLC (LSE:ULVR) announced a new €3bn share buyback and said it does not intend to pursue any more acquisitions in the foreseeable future, following the failed bid for GlaxoSmithKline's consu

LONDON (Reuters) -Unilever forecast higher sales, but lower margins, this year as it grapples with soaring inflation, and ruled out big acquisitions following recent investor criticism of its failed p

By Richa Naidu and Ross Kerber LONDON/BOSTON (Reuters) – Criticised by a major investor for focusing on sustainability more than financial performance, Unilever CEO Alan Jope will be under pressure at the consumer goods group’s quarterly results on Thursday to show the two can go hand in hand.

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Wednesday Market Open) No news may be good news as equity index futures are pointing to a higher open on another day of light economic announcements. There are several earnings announcements but no big companies that are likely to have far-reaching effects on the market. The higher premarket move could be an impressive follow up to yesterday’s rally. Crude oil prices and yields were lower before the market open which appears to be helping equity futures. Lower oil and yields are helping reduce investor fears as the Cboe Market Volatility Index (VIX) was 3.5% lower in premarket trading and nearing 20. Many of the earnings reports this morning are positive, starting with Toyota (NYSE: TM). The automaker reported better-than-expected earnings and revenues. TM had to cut its production targets due to the semiconductor shortage, but the stock was relatively unmoved in premarket trading.

Market Futures Higher Ahead of Opening

What now for AstraZeneca?  Coming the day after GSK, its former larger rival, AstraZeneca PLC reports following the closure of its Alexion acquisition halfway through last year.

Criticised by a major investor for focusing on sustainability more than financial performance, Unilever CEO Alan Jope will be under pressure at the consumer goods group's quarterly results on Thursday

GSK racked up 1.4 billion pounds (US$1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, as it beat quarterly forecasts in its first earnings report since rejecting a bid from Unilever for its consumer arm. The British drugmaker said it expected pandemic-related sales in 2022